Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to present current and comprehensive recommendations for surgical treatment of this hematoma and to determine the factors that may improve the survival rate


Clinical Trial Description

Spontaneous intracerebral hemorrhage is a common, mostly deadly stroke subtype and accounts for 10% to 15% of all strokes. It's associated with a higher mortality rate (44% after 30 days) than either ischemic stroke or subarachnoid hemorrhage Up to 75% of the long term survivors are often suffering significant disability and only 12% to 39% of the survivors have favourable neurological functions recovered Rapid diagnosis and attentive management of patients is crucial because early deterioration is common Neurosurgical treatment for ICH has been discussed in recent multicentric studies, but no definitive answer of its utility has emerged. Improved surgical techniques , neuroimaging, neuroanesthesia and perioperative monitoring and care have all led to improved outcomes from surgery ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06309940
Study type Observational
Source Assiut University
Contact Ahmed Sameeh, Master
Phone 01022690894
Email ahmedsameeh18497@gmail.com
Status Not yet recruiting
Phase
Start date March 2024
Completion date April 2025